People · Operator
Named in public records as an officer, director or promoter · active 2010–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ferrokin Biosciences Inc | — | Biotechnology | Series A | $24.0M | $108.5M | 2010 |
Hugh Y. Rienhoff, Jr., M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hugh Y. Rienhoff, Jr., M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bryant E. Fong | 1 | 2 |
| Hugh Y. Rienhoff, Jr. | 1 | 2 |
| Marten E. Steen | 1 | 1 |
| Dennis E. Henner, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.